Clinical Trial Update: Relative Bioavailability Study of GSK1265744 Formulations [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study of cabotegravir formulations completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Viral Hepatitis

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Hepatitis | Phase 1 | Status: COMPLETED